Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
Using a life satisfaction measure in the valuation of health: A case study of multiple sclerosis.
Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Immune surveillance and response to JC virus infection and PML.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
C1-C2 X-Ray assessment of misalignment parameters in patients with Chronic Cerebra-spinal Venous Insufficiency and Multiple Sclerosis versus patients with other pathologies.
Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
Can we measure long-term treatment effects in multiple sclerosis?
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
The relationship between muscle pain and fatigue.
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
Therapeutic potential of cannabinoid medicines.
Pages
« first
‹ previous
…
386
387
388
389
390
391
392
393
394
…
next ›
last »